IM8N Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Insmed Inc

Watchlist Manager

Watchlist

Price: 100 EUR -2.44% Market Closed

Market Cap: €16.3B

I	Insmed Inc F:IM8N	US
	Intesa Sanpaolo SpA MIL:ISP	IT
E	Eltel AB SWB:E5E	SE
	Data I/O Corp NASDAQ:DAIO	US
	Coveo Solutions Inc OTC:CVOSF	CA
C	Carabao Group PCL SET:CBG	TH
S	Super Group Ltd XBER:S8G1	ZA
G	Gaming and Leisure Properties Inc F:2GL	US
	Bank Rakyat Indonesia (Persero) Tbk PT IDX:BBRI	ID
	Geron Corp NASDAQ:GERN	US
	Bank Mandiri (Persero) Tbk PT IDX:BMRI	ID

Profitability Summary

Insmed Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

78% > 82%

Negative Operating Margin

-141%

Negative 3Y Average Operating Margin

-211%

Operating Margin is Increasing

-208% > -141%

Negative Net Margin

-144%

Negative 3Y Average Net Margin

-241%

Net Margin is Increasing

-212% > -144%

Negative Free Cash Flow Margin

-112%

Negative 3Y Average Free Cash Flow Margin

-182%

Free Cash Flow Margin is Increasing

-176% > -112%

Negative ROE

-294%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-157%

Declining ROIC

-115% > -176%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.